Literature DB >> 23683103

Assessment of insulin action on carbohydrate metabolism: physiological and non-physiological methods.

S Dube1, I Errazuriz, C Cobelli, R Basu, A Basu.   

Abstract

Carbohydrate metabolism in humans is regulated by insulin secretion from pancreatic β-cells and glucose disposal by insulin-sensitive tissues. Insulin facilitates glucose utilization in peripheral tissues and suppresses hepatic glucose production. Any defects in insulin action predispose an individual to glucose intolerance and Type 2 diabetes mellitus. Early detection of defects in insulin action could provide opportunities to prevent or delay progression of the disease state. There are different approaches to assess insulin action. Initial methods, such as peripheral insulin concentration and simple indices, have several limitations. Subsequently, researchers developed methodologies using intravenous glucose infusion to determine glucose fluxes. However, these methodologies are limited by being non-physiological. Newer, innovative techniques that have been developed are more sophisticated and physiological. By modelling glucose kinetics using isotope dilution techniques, several robust parameters can be obtained that are physiologically relevant and sound. This brief review summarizes most of the non-physiological and physiological methodologies used to measure the variables of insulin action.
© 2013 The Authors. Diabetic Medicine © 2013 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23683103      PMCID: PMC3662485          DOI: 10.1111/dme.12189

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  35 in total

1.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method.

Authors:  R STEELE; J S WALL; R C DE BODO; N ALTSZULER
Journal:  Am J Physiol       Date:  1956-09

2.  Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model.

Authors:  Chiara Dalla Man; Andrea Caumo; Rita Basu; Robert Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-21       Impact factor: 4.310

3.  Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus.

Authors:  K LUNDBAEK
Journal:  Br Med J       Date:  1962-06-02

4.  Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.

Authors:  A Basu; A Caumo; F Bettini; A Gelisio; A Alzaid; C Cobelli; R A Rizza
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

5.  Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT.

Authors:  C Cobelli; G Pacini; G Toffolo; L Saccà
Journal:  Am J Physiol       Date:  1986-05

6.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

7.  Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods.

Authors:  A Mari; J Wahren; R A DeFronzo; E Ferrannini
Journal:  Metabolism       Date:  1994-11       Impact factor: 8.694

8.  Stable-label intravenous glucose tolerance test minimal model.

Authors:  A Avogaro; J D Bristow; D M Bier; C Cobelli; G Toffolo
Journal:  Diabetes       Date:  1989-08       Impact factor: 9.461

9.  Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes.

Authors:  G Livesey; P D Wilson; J R Dainty; J C Brown; R M Faulks; M A Roe; T A Newman; J Eagles; F A Mellon; R H Greenwood
Journal:  Am J Physiol       Date:  1998-10

10.  A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.

Authors:  M F Saad; R L Anderson; A Laws; R M Watanabe; W W Kades; Y D Chen; R E Sands; D Pei; P J Savage; R N Bergman
Journal:  Diabetes       Date:  1994-09       Impact factor: 9.461

View more
  6 in total

1.  Nighttime light exposure enhances Rev-erbα-targeting microRNAs and contributes to hepatic steatosis.

Authors:  Patricia C Borck; Thiago M Batista; Jean F Vettorazzi; Gabriela M Soares; Camila Lubaczeuski; Dongyin Guan; Antonio C Boschero; Elaine Vieira; Mitchell A Lazar; Everardo M Carneiro
Journal:  Metabolism       Date:  2018-05-08       Impact factor: 8.694

2.  Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Anusha Vittal; Mark Shapses; Bashar Sharma; Disha Sharma; Qian Sun; Maureen Sampson; Wilson Lee; Gil Ben Yakov; Yaron Rotman
Journal:  Hepatol Commun       Date:  2020-12-29

3.  Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.

Authors:  Attila A Seyhan; Yury O Nunez Lopez; Hui Xie; Fanchao Yi; Clayton Mathews; Magdalena Pasarica; Richard E Pratley
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

4.  Hypoglycemic activity of the ethyl acetate extract from Smilax glabra Roxb in mice: Biochemical and histopathological studies.

Authors:  Phuong Thi Mai Nguyen; Quang Van Ngo; Minh Thi Hong Nguyen; Lien Thi Quach; Stephen G Pyne
Journal:  Iran J Basic Med Sci       Date:  2020-12       Impact factor: 2.699

5.  The control of hyperglycemia by a novel trypsin resistant oral insulin preparation in alloxan induced type I diabetic mice.

Authors:  Sarbashri Bank; Arjun Ghosh; Suman Bhattacharya; Smarajit Maiti; Gausal A Khan; Asru K Sinha
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

6.  Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults.

Authors:  Desiree M Sigala; Bettina Hieronimus; Valentina Medici; Vivien Lee; Marinelle V Nunez; Andrew A Bremer; Chad L Cox; Candice A Price; Yanet Benyam; Abhijit J Chaudhari; Yasser Abdelhafez; John P McGahan; Michael I Goran; Claude B Sirlin; Giovanni Pacini; Andrea Tura; Nancy L Keim; Peter J Havel; Kimber L Stanhope
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.